Profiel
Krystof S.
Bankiewicz is the founder of Voyager Therapeutics, Inc. (founded in 2013) and Brain Neurotherapy Bio, Inc. (founded in 2018).
At Brain Neurotherapy Bio, Inc., he held the title of Chief Executive Officer from 2018 to 2024.
Currently, Dr. Bankiewicz is the Director-Interventional Neurology Center at The University of California, San Francisco.
Dr. Bankiewicz holds a doctorate degree from Uniwersytet Jagiellonski and Instytut Psychiatrii I Neurologii.
Actieve functies van Krystof S. Bankiewicz
| Bedrijven | Functie | Begin |
|---|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Eerdere bekende functies van Krystof S. Bankiewicz
| Bedrijven | Functie | Einde |
|---|---|---|
Brain Neurotherapy Bio, Inc.
Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative neurological gene therapies that restore and preserve health and well-being | Algemeen Directeur | 01-02-2024 |
| VOYAGER THERAPEUTICS, INC. | Oprichter | - |
Opleiding van Krystof S. Bankiewicz
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uniwersytet Jagiellonski
Uniwersytet Jagiellonski Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instytut Psychiatrii I Neurologii
Instytut Psychiatrii I Neurologii Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Brain Neurotherapy Bio, Inc.
Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative neurological gene therapies that restore and preserve health and well-being | Commercial Services |
















